Board of Directors 2026-2027
President (2026-2027)
Beth Devine, PhD, PharmD, MBA
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA
Past-President (2026-2027)
Uwe Siebert, MPH, MSc, ScD
Professor for Public Health, Medical Decision Making and Health Technology Assessment
UMIT TIROL - University for Health Sciences and Technology
Tirol, Austria
President-Elect (2026-2027)
Lotte Steuten, PhD, MSc
Deputy Chief Executive
Office of Health Economics (OHE)
London, UK
Director (2024-2027)
Elisabeth Fenwick, PhD, MSc
Chief Science Officer
Open Health Group
London, England, UK
Director (2024-2027)
Ramiro Gilardino, MD, MSc
Healthcare Executive
Zurich, Switzerland
Director (2026-2029)
Sandra Nestler-Parr, PhD, MPhil, MSc
Senior Vice President, Value & Patient Access
BioCryst Pharmaceuticals
Durham, NC, USA
Biography and Vision Statement
Director (2024-2027)
Daniel Ollendorf, PhD
Chief Scientific Officer and Director of HTA Methods and Engagement
Institute for Clinical and Economic Review
Boston, MA, USA
Director (2026-2029)
William Padula, PhD, MS, MSc
Associate Professor, University of Southern California
Senior Scholar, The Schaeffer Institute Co-Founder and Principal, Stage Analytics
Los Angeles, CA
Biography and Vision Statement
Director (2024-2027)
Katja Rudell, PhD
Vice President, Patient Centred Outcomes
Kielo Research
Cambridge, United Kingdom
Director (2026-2029)
Jing Wu, PhD
Chair, Pharmacoeconomics Professional Committee
Chinese Pharmaceutical Association
Beijing, China
Treasurer (2026-2029)
Jens Grueger, PhD
Affiliate Professor of Health Economics, CHOICE Institute
University of Washington, Seattle, WA
Freiburg, Baden-Wuerttemberg, Germany
Biography and Vision Statement
Chief Executive Officer
Rob Abbott
Chief Executive Officer
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, New Jersey, USA